The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.00
Bid: 274.00
Ask: 278.00
Change: -7.00 (-2.51%)
Spread: 4.00 (1.46%)
Open: 273.00
High: 279.00
Low: 272.00
Prev. Close: 279.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Swordfish Dive Support Vessel sold for US$24m

28 Dec 2022 07:00

RNS Number : 9727K
Fisher (James) & Sons plc
28 December 2022
 

This announcement contains inside information

 

28 December 2022

 

James Fisher and Sons plc

Swordfish Dive Support Vessel sold for US$24m

 

James Fisher and Sons plc (FSJ.L) ("James Fisher" or the "Group"), the leading marine services provider, announces that the Group has entered into a Memorandum of Agreement (the "Sale Agreement") for the sale of the Subtech Swordfish Dive Support Vessel (the "Swordfish" or the "Vessel") to Seamec Limited, a company incorporated in India, for a cash consideration of US$24 million (approximately £19.8 million). The transaction remains subject to completion of the formal sale process, including issuing of Notice of Readiness and completion of flag requirements.

 

The Swordfish has been on customer contract with an international energy services company during 2022, supporting diving activities in the Middle East. The Sale Agreement allows for the Group to maintain access to the Vessel until the end of Q3 2023, enabling it to complete existing and potential customer commitments.

 

The sale of the Swordfish is a further demonstration of the Group's previously announced asset-light strategy. The Group is establishing partnerships with vessel owners to facilitate access to multiple dive support vessels in the region. 

 

The Vessel contributed £0.4m in Gross Profit to the Marine Support division for the year ended 31 December 2021, prior to any allocation of indirect overheads. The Vessel was designated as held for sale in the Group's 2022 Interim financial statements, with a book value of £13.0m. The proceeds will be applied to further reduce the Group's net borrowings.

 

 

For further information:  

James Fisher and Sons plc 

Jean Vernet 

Duncan Kennedy 

Chief Executive Officer 

Chief Financial Officer 

01229 615400 

FTI Consulting  

Richard Mountain 

Susanne Yule 

0203 727 1340 

 

The person responsible for making this announcement on behalf of the Company is Duncan Kennedy, Chief Financial Officer, James Fisher and Sons plc. 

 

LEI: 213800J975E5OYR6S216 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXAXAESAFFA
Date   Source Headline
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings
13th Feb 20245:50 pmRNSHolding(s) in Company
8th Feb 20247:00 amRNSFull Year Trading Update
25th Jan 20247:00 amRNSAppointment of Independent Non-Executive Director
20th Dec 20236:06 pmRNSNotification of Director’s Interests in Shares
15th Dec 20233:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Nov 20234:06 pmRNSHolding(s) in Company
9th Nov 20231:59 pmRNSBoard Changes
26th Oct 20237:30 amRNSDirector Declaration
2nd Oct 20239:00 amRNSTotal Voting Rights and Share Capital
25th Sep 202311:29 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHalf year results
3rd Aug 20237:00 amRNSAppointment of Chief Financial Officer
17th Jul 20237:01 amRNSBoard Change
17th Jul 20237:00 amRNSHalf year trading update
6th Jul 20237:00 amRNSHolding(s) in Company
15th Jun 20233:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Jun 20234:18 pmRNSResults of Annual General Meeting (“AGM”)
14th Jun 20237:00 amRNSAGM Trading Statement
12th Jun 20234:24 pmRNSNotification of Directors' Interests in Shares
9th Jun 20233:53 pmRNSNotification of Directors' Interest in Shares
7th Jun 20237:00 amRNSCompletion of refinancing
12th May 20234:49 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
2nd May 20237:00 amRNSUpdate on full year results
28th Apr 20237:58 amRNSFull year results for the year ended 31 Dec 2022
26th Apr 20237:00 amRNSAgreed Revolving Credit Facility
28th Mar 20232:00 pmRNSHolding(s) in Company
24th Mar 20237:00 amRNSCorporate, Financing and Trading Update
6th Mar 20237:00 amRNSSale of JFN, Trading Update and Notice of Results
28th Dec 20227:00 amRNSSwordfish Dive Support Vessel sold for US$24m
19th Dec 20227:00 amRNSDisposal of three businesses
15th Dec 20224:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
19th Oct 20229:14 amRNSHolding(s) in Company
13th Sep 202212:59 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSCompany Secretary Change
29th Jul 20224:39 pmRNSHolding(s) in Company
23rd Jun 20222:06 pmRNSHolding(s) in Company
17th Jun 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 20224:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jun 20227:00 amRNSCEO Update
6th May 20225:42 pmRNSHolding(s) in Company
5th May 20225:05 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Statement
25th Apr 20221:42 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted
22nd Mar 20224:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.